MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Carcinoid Tumor

(UMLS:C0007095)

Definition:: A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)
UMLS ID:: C0007095
MeSH ID:: D002276

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.465.625.650.200|C04.557.470.200.025.200|C04.557.580.625.650.200

Synonym(s)

Carcinoid Tumor

CARCINOID

CARCINOID TUMOR

Carcinoid

Carcinoid Tumors

Carcinoid tumor

Carcinoid tumor - morphology

Carcinoid tumors

Carcinoid tumour

10.

Carcinoid tumour - morphology

11.

Carcinoid tumours

Associated Drug(s)

	Name	Reference(s)	Data Source
1	AG-041R	10461356	CTD
2	Dacarbazine	16051944	CTD
3	Doxorubicin	16051944	CTD
4	Fluorouracil	16051944	CTD
5	Octreotide	2319110 11416760	CTD
6	Streptozocin	16051944	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	melanoma	51.5%
2	Neoplasms, Neuroepithelial	51.2%
3	Gliomatosis cerebri	51.2%
4	Adenoma, Acidophil	49.6%
5	Paraganglioma	47%
6	Neurilemmoma	46%
7	Craniopharyngioma	40.3%
8	Neuroectodermal Tumor, Melanotic	40.3%
9	Hutchinson's Melanotic Freckle	36.5%
10	Melanoma, Amelanotic	36.5%
11	Cystadenocarcinoma	36%
12	Mucoepidermoid Carcinoma	36%
13	Pheochromocytoma	35.1%
14	Melanoma, Experimental	33.3%
15	leukemia	33.1%
16	Ganglioneuroma	32.6%
17	Glioma	32.6%
18	Malignant Glioma	32.6%
19	Basal cell carcinoma	32.6%
20	Carcinoma, Papillary	32.6%
21	Squamous cell carcinoma	32.6%
22	Carcinoma, Basal Cell	32.6%
23	Medulloblastoma	31.3%
24	Adenoid Cystic Carcinoma	29.4%
25	Adenocarcinoma, Clear Cell	29.4%
26	Cholangiocarcinoma	29.4%
27	Choriocarcinoma	29.4%
28	Carcinoma, Lobular	29.4%
29	Carcinoma, Ehrlich Tumor	29.3%
30	Carcinoma, Lewis Lung	29.3%
31	Meningioma	26.7%
32	Histiocytic Disorders, Malignant	26.6%
33	Adenoma	26.1%
34	Chordoma	26.1%
35	Teratoma	26.1%
36	Germinoma	26.1%
37	Teratocarcinoma	26.1%
38	Trophoblastic Neoplasms	25.2%
39	Carcinoma in Situ	25.1%
40	Carcinoma, Transitional Cell	25.1%
41	Carcinoma, Large Cell	25.1%
42	Carcinoma, Small Cell	25.1%
43	Cystadenoma	24.9%
44	Mesothelioma	24.9%
45	Astrocytoma	23.5%
46	Ependymoma	23.5%
47	oligodendroglioma	23.5%
48	Ganglioglioma	23.5%
49	gliosarcoma	23.5%
50	Anaplastic astrocytoma	23.5%
51	Anaplastic Oligodendroglioma	23.5%
52	Carcinosarcoma	23.2%
53	Hemangiosarcoma	23.2%
54	lymphangiosarcoma	23.2%
55	Lymphoma	22.2%
56	Neoplasms, Germ Cell and Embryonal	22%
57	Neoplasms, Glandular and Epithelial	22%
58	Germ Cell Cancer	22%
59	Klatskin Tumor	22%
60	Bowen's Disease	21.6%
61	Hamartoma	21.5%
62	Neoplasms, Hormone-Dependent	21.5%
63	Neoplasms, Multiple Primary	21.5%
64	Paraneoplastic Syndromes	21.5%
65	Precancerous Conditions	21.5%
66	Neoplasms, Second Primary	21.5%
67	Dermoid Cyst	21.5%
68	Retinoblastoma	21.5%
69	Composite Lymphoma	20.8%
70	Leukemia, Experimental	19.6%
71	Acoustic Neuroma	19.6%
72	Vipoma	19.6%
73	Carcinoma 256, Walker	19.5%
74	Neuroectodermal Tumors	19.4%
75	Leukemia, Plasma Cell	19.3%
76	Glioblastoma	18.9%
77	Neuroblastoma	18.9%
78	Glioblastoma Multiforme	18.9%
79	Ameloblastoma	18.1%
80	Angiokeratoma	18.1%
81	Hemangioma	18.1%
82	hemangiopericytoma	18.1%
83	Lymphangioma	18.1%
84	Mesenchymoma	18.1%
85	Nevus	18.1%
86	Hepatoblastoma	18.1%
87	Mixed Tumor, Mullerian	18.1%
88	Angiofibroma	18.1%
89	Sarcoma	18.1%
90	Cyst	17.4%
91	Neoplastic Processes	17.4%
92	Neoplastic Syndromes, Hereditary	17.4%
93	Pregnancy Complications, Neoplastic	17.4%
94	Acanthoma	17.4%
95	Chondrosarcoma	17.3%
96	leiomyosarcoma	17.3%
97	liposarcoma	17.3%
98	synovial sarcoma	17.3%
99	Angiomyolipoma	17.3%
100	Clear Cell Sarcoma of Soft Tissue	17.3%
101	Alveolar Soft Part Sarcoma	17.3%
102	Sarcoma, Myeloid	17.3%
103	Neoplasms, Experimental	17.2%
104	Leukemia, Radiation-Induced	17%
105	Adenofibroma	16.7%
106	Fibroadenoma	16.7%
107	Ganglioneuroblastoma	16.7%
108	Cervical Intraepithelial Neoplasia	16.7%
109	Carcinoma, Pancreatic Ductal	16.1%
110	Adrenocortical carcinoma	16%
111	Dysgerminoma	15.5%
112	Neuroma	15.5%
113	Papilloma	15.5%
114	Pseudomyxoma Peritonei	15.5%
115	Seminoma	15.5%
116	Papillomatosis	15.5%
117	Adenomatosis, Pulmonary	15.5%
118	Adenomatous Polyps	15.5%
119	Sarcoma, Experimental	14.6%
120	Plasmacytoma	14.6%
121	Thymoma	14.6%
122	Malignant histiocytosis	14.5%
123	Histiocytic sarcoma	14.5%
124	Multiple Endocrine Neoplasia	14.5%
125	Neoplasms, Radiation-Induced	14.4%
126	Endometrial Stromal Sarcoma	14.3%
127	Fibrosarcoma	14.3%
128	Osteosarcoma	14.3%
129	Renal Cell Carcinoma	14.2%
130	Papillary Renal Cell Carcinoma	14.2%
131	Carcinoma, Endometrioid	13.8%
132	Basal Cell Nevus Syndrome	13.7%
133	Leukemia L1210	13.5%
134	Leukemia P388	13.5%
135	Malignant Fibrous Histiocytoma	12.9%
136	Carcinoma, Ovarian Epithelial	12.8%
137	Lymphangioleiomyomatosis	12.4%
138	Optic Nerve Glioma	12.2%
139	Hodgkin Disease	12.1%
140	Lymphoma, Non-Hodgkin	12.1%
141	Carcinoma	12%
142	Epithelioma	12%
143	Gastrinoma	12%
144	Glucagonoma	12%
145	Paraneoplastic Encephalomyelitis	11.6%
146	Nephroblastoma	11.5%
147	Neuroendocrine Tumors	11.5%
148	Mammary Neoplasms, Experimental	11.4%
149	Rhabdomyosarcoma	11.4%
150	Giant Cell Tumor of Bone	11.4%
151	Neurofibrosarcoma	11.4%
152	Tuberous Sclerosis	11.3%
153	Hepatocellular Adenoma	11.1%
154	Abdominal Neoplasms	11%
155	Erythroplasia	11%
156	Follicular cyst	11%
157	Head and Neck Neoplasms	11%
158	Mucocele	11%
159	Pilonidal Cyst	11%
160	Soft Tissue Neoplasms	11%
161	Thoracic Neoplasms	11%
162	Thyroglossal Cyst	11%
163	Synovial Cyst	11%
164	Aberrant Crypt Foci	11%
165	Nasopharyngeal carcinoma	10.8%
166	Phyllodes Tumor	10.8%
167	Hemangioendothelioma	10.8%
168	Lipoma	10.8%
169	Myoma	10.8%
170	Myxoma	10.8%
171	Angiolipoma	10.8%
172	Myelolipoma	10.8%
173	Neoplasms, Bone Tissue	10.8%
174	Neoplasms, Fibrous Tissue	10.8%
175	Smooth Muscle Tumor	10.8%
176	Desmoplastic Small Round Cell Tumor	10.8%
177	Chondroma	10.8%
178	Enchondroma	10.8%
179	Sarcoma 180	10.6%
180	Primary amyloidosis	10.4%
181	neurofibroma	10.4%
182	Lymphomatoid Granulomatosis	10.3%
183	Dermatofibrosarcoma	10%
184	Dermatofibrosarcoma Protuberans	10%
185	Prolactinoma	9.7%
186	Growth Hormone-Secreting Pituitary Adenoma	9.7%
187	Carcinoid Tumor	9.5%
188	Hydatidiform Mole	9.3%
189	Digestive System Neoplasms	9.2%
190	Endocrine Gland Neoplasms	9.2%
191	Eye Neoplasms	9.2%
192	Nervous System Neoplasms	9.2%
193	Mesoblastic Nephroma	9.1%
194	Bone neoplasms	9%
195	Leukoplakia	9%
196	Lymphocele	9%
197	Pancreatic Cyst	9%
198	Skin Neoplasms	9%
199	Hematologic Neoplasms	9%
200	Barrett Esophagus	8.9%
201	Breast Cyst	8.9%
202	Actinic keratosis	8.9%
203	Mediastinal Cyst	8.9%
204	Neoplasm Invasiveness	8.9%
205	Neoplasm Metastasis	8.9%
206	Neoplasm Recurrence, Local	8.9%
207	Parovarian Cyst	8.9%
208	Pericardial Cyst	8.9%
209	Splenic Neoplasms	8.9%
210	Thymic Cyst	8.9%
211	Carcinogenesis	8.9%
212	Myxoid cyst	8.9%
213	Metastasis	8.9%
214	Leukemia, Myelomonocytic, Chronic	8.6%
215	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	8.6%
216	Alveolar rhabdomyosarcoma	8.5%
217	Waldenstrom Macroglobulinemia	8.1%
218	Multiple Myeloma	8.1%
219	Multiple Endocrine Neoplasia Type 1	7.9%
220	Adenomatous Polyposis Coli	7.7%
221	Liver Neoplasms, Experimental	7.4%
222	Mastocytosis	7.4%
223	Sturge-Weber Syndrome	7.4%
224	Corpus Luteum Cyst	7.3%
225	Ovarian Cysts	7.3%
226	Gastrointestinal Stromal Tumors	7.3%
227	Hemangioma, Cavernous	7.2%
228	Leukemia, T-Cell	7.2%
229	Leukemia, B-Cell	7.2%
230	Adenocarcinoma	7.2%
231	Lymphoma, Follicular	7.2%
232	T-Cell Lymphoma	7.2%
233	Mantle cell lymphoma	7.2%
234	fibroma	7.1%
235	Fibromatosis	7.1%
236	Osteoblastoma	7.1%
237	Osteoma	7.1%
238	Rhabdomyoma	7.1%
239	Chondromatosis	7.1%
240	Hemangioblastoma	7.1%
241	Lymphoma, Extranodal NK-T-Cell	7.1%
242	Parathyroid Neoplasms	7.1%
243	Peritoneal Neoplasms	7.1%
244	Thyroid Neoplasm	7.1%
245	Thyroid carcinoma	7.1%
246	Malignant Carcinoid Syndrome	7.1%
247	insulinoma	6.7%
248	Choledochal Cyst	6.4%
249	granulosa cell tumor	6.4%
250	Pancreatic Neoplasm	6.3%
251	Peutz-Jeghers Syndrome	6.3%
252	Retroperitoneal Neoplasms	6%
253	Mastocytoma	5.8%
254	Mastocytosis, Systemic	5.7%
255	Leukemia, Myeloid, Chronic-Phase	5.7%
256	Tracheal Neoplasms	5.7%
257	Leukoplakia, Oral	5.6%
258	Paraneoplastic Cerebellar Degeneration	5.5%
259	Fibromatosis, Aggressive	5.3%
260	Fibromatosis, Abdominal	5.3%
261	Carcinoid Heart Disease	5.2%
262	Denys-Drash Syndrome	4.9%
263	Mouth Neoplasms	4.9%
264	Central Nervous System Neoplasms	4.9%
265	Vascular Neoplasms	4.9%
266	Thymus Neoplasms	4.9%
267	Esophageal Neoplasms	4.9%
268	Genital Neoplasms, Female	4.9%
269	Pancreatic Pseudocyst	4.9%
270	Limbic Encephalitis	4.8%
271	Lymphatic Metastasis	4.8%
272	Neoplasms, Unknown Primary	4.8%
273	Leukemic Infiltration	4.8%
274	Breast Neoplasms, Male	4.8%
275	Neoplasm Micrometastasis	4.8%
276	Triple Negative Breast Neoplasms	4.8%
277	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	4.8%
278	Leukemia, Large Granular Lymphocytic	4.8%
279	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	4.8%
280	Lymphoma, T-Cell, Cutaneous	4.7%
281	Lymphoma, AIDS-Related	4.7%
282	Enteropathy-Associated T-Cell Lymphoma	4.7%
283	Primary Effusion Lymphoma	4.7%
284	Leydig Cell Tumor	4.5%
285	Lambert-Eaton Myasthenic Syndrome	4.4%
286	Testicular Neoplasms	4.4%
287	Thyroid Nodule	4.2%
288	Adrenal Gland Neoplasms	4.2%
289	Gastrointestinal Neoplasms	4.2%
290	Genital Neoplasms, Male	4.2%
291	Liver neoplasms	4.2%
292	Uveal Neoplasms	4.2%
293	Urologic Neoplasms	4.1%
294	Sebaceous Gland Neoplasms	4.1%
295	Spinal Neoplasms	4.1%
296	Bone Marrow Neoplasms	4.1%
297	Xeroderma Pigmentosum	4.1%
298	Polycystic Ovary Syndrome	4%
299	Opsoclonus-Myoclonus Syndrome	3.9%
300	Dupuytren Contracture	3.7%
301	Urticaria Pigmentosa	3.6%
302	Burkitt Lymphoma	3.6%
303	Mycosis Fungoides	3.6%
304	Lymphomatoid Papulosis	3.6%
305	Plasmablastic lymphoma	3.6%
306	Myelitis, Transverse	3.5%
307	ovarian neoplasm	3.1%
308	Nose Neoplasms	3%
309	Meningeal Neoplasms	2.9%
310	Pituitary Adenoma	2.8%
311	Pituitary Neoplasms	2.8%
312	Sezary Syndrome	2.7%
313	Palatal Neoplasms	2.7%
314	Ear Neoplasms	2.5%
315	Eyelid Neoplasms	2.5%
316	Lung Neoplasms	2.5%
317	Pleural Neoplasms	2.5%
318	Zollinger-Ellison syndrome	2.4%
319	Cell Transformation, Viral	2.4%
320	Brain Neoplasms	2.4%
321	Salivary Gland Neoplasms	2.4%
322	Spinal Cord Neoplasms	2.4%
323	Tongue Neoplasms	2.4%
324	Uterine Neoplasms	2.4%
325	Vaginal Neoplasms	2.4%
326	Vulvar Neoplasms	2.4%
327	Uterine Cancer	2.4%
328	Fallopian Tube Neoplasms	2.4%
329	Pharyngeal Neoplasms	2.1%
330	Central Nervous System Cysts	2.1%
331	Bile Duct Neoplasms	2.1%
332	gallbladder neoplasm	2.1%
333	Intestinal Neoplasms	2.1%
334	Penile Neoplasms	2.1%
335	Prostatic Neoplasms	2.1%
336	Stomach Neoplasms	2.1%
337	Polycythemia Vera	2.1%
338	Meningeal Carcinomatosis	1.9%
339	Laryngeal neoplasm	1.9%
340	Bladder Neoplasm	1.8%
341	Kidney Neoplasm	1.8%
342	Ureteral Neoplasms	1.8%
343	Urethral Neoplasms	1.8%
344	Bronchial Neoplasms	1.6%
345	Multiple Pulmonary Nodules	1.6%
346	Supratentorial Neoplasms	1.6%
347	Endometrial Neoplasms	1.6%
348	Hypopharyngeal Neoplasms	1.4%
349	Pleural Effusion, Malignant	1.4%
350	Hypopharyngeal Cancer	1.4%
351	Parotid Neoplasms	1.4%
352	Prostatic Neoplasms, Castration-Resistant	1.4%
353	Nelson Syndrome	1.4%
354	Cecal Neoplasms	1.2%
355	Duodenal Neoplasms	1.2%
356	Brain Stem Neoplasms	1.2%
357	Nasopharyngeal Neoplasms	1.1%
358	Colorectal Neoplasms	1.1%
359	Tonsillar Neoplasms	1%
360	Cerebellar Neoplasms	1%
361	Choroid Plexus Papilloma	1%
362	Paranasal Sinus Neoplasms	1%
363	Radicular Cyst	0.9%
364	Appendiceal Neoplasms	0.9%
365	Colonic Neoplasms	0.9%
366	Rectal Neoplasms	0.9%
367	Maxillary Sinus Neoplasms	0.7%
368	Anus Neoplasms	0.7%
369	Sigmoid Neoplasms	0.7%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234